Exosomal proteins as prognostic biomarkers in non-small cell lung cancer

Use of exosomes as biomarkers in non-small cell lung cancer (NSCLC) is an intriguing approach in the liquid-biopsy era. Exosomes are nano-sized vesicles with membrane-bound proteins that reflect their originating cell. Prognostic biomarkers are needed to improve patient selection for optimal treatment. We here evaluate exosomes by protein phenotyping as a prognostic biomarker in NSCLC.

Source: Molecular Oncology - October 20, 2016 Category: Cancer & Oncology Authors: B. Sandfeld-Paulsen, N. Aggerholm-Pedersen, R. B æk, K.R. Jakobsen, P. Meldgaard, B.H. Folkersen, T.R. Rasmussen, K. Varming, M.M. Jørgensen, B.S. Sorensen Source Type: research